Zehua P. Ma
Guiyang, 550001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Antiandrogen therapy induces mitochondrial oxidative phosphorylation to promote castration resistance in prostate cancer.
Journal: Free radical biology & medicine
Published: February 20, 2026
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 22, 2025
Correction to: Urinary extracellular vesicle‑derived miR‑126‑3p predicts lymph node invasion in patients with high‑risk prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: March 21, 2025
A modified strategy in robot-assisted laparoscopic partial nephrectomy for localized renal tuberculosis: the "unroofing and base excision" technique and clinical outcomes.
Journal: Translational andrology and urology
Published: January 14, 2025
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway.
Journal: Cancer letters
Published: August 22, 2024
A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
Journal: The Journal of urology
Published: April 09, 2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: March 25, 2024
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Journal: Nature communications
Published: April 06, 2023
Identification of cancer-associated fibroblasts subtypes in prostate cancer.
Journal: Frontiers in immunology
Published: December 28, 2022
Last Updated: 09/26/2026